Implications of Necroptosis for Cardiovascular Diseases

Abstract

Necroptosis is a non-apoptotic programmed cell death pathway, which causes necrosis-like morphologic changes and triggers inflammation in the surrounding tissues. Accumulating evidence has demonstrated that necroptosis is involved in a number of pathological processes that lead to cardiovascular diseases. However, the exact molecular pathways linking them remain unknown. Herein, this review summarizes the necroptosis-related pathways involved in the development of various cardiovascular diseases, including atherosclerosis, cardiac ischemia-reperfusion injury, cardiac hypertrophy, dilated cardiomyopathy and myocardial infarction, and may shed light on the diagnosis and treatment of these diseases.

Keywords

cell death / death-associated molecular patterns / necroptosis / cardiovascular disease

References

[1] Al-MallahMH, SakrS, Al-QunaibetA. Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update. Curr Atheroscler Rep, 2018, 20(1): 1

[2] ReamyBV, WilliamsPM, KuckelDP. Prevention of Cardiovascular Disease. Primary Care, 2018, 45(1): 25-44

[3] BrunvandH, OieE. Apoptosis and cardiovascular disease. Tidsskr Nor laegeforen (Norwegian), 2003, 123(7): 930-932

[4] ChenQ, ThompsonJ, HuY, et al.. Cardiac Specific Knockout of p53 Decreases ER Stress-Induced Mitochondrial Damage. Front Cardiovasc Med, 2019, 6: 10

[5] HaunstetterA, IzumoS. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res, 1998, 82(11): 1111-1129

[6] MughalW, DhingraR, KirshenbaumLA. Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep, 2012, 14(6): 540-547

[7] ZhouW, YuanJ. Necroptosis in health and diseases. Semin Cell Dev Biol, 2014, 35: 14-23

[8] SzobiA, GoncalvesovaE, VargaZV, et al.. Analysis of necroptotic proteins in failing human hearts. J Transl Med, 2017, 15(1): 86

[9] GalluzziL, MaiuriMC, VitaleI, et al.. Cell death modalities: classification and pathophysiological implications. Cell Death Differ, 2007, 14(7): 1237-1243

[10] NorburyCJ, HicksonID. Cellular responses to DNA damage. Ann Rev Pharmacol Toxicol, 2001, 41: 367-401

[11] IgneyFH, KrammerPH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer, 2002, 2(4): 277-288

[12] GozuacikD, KimchiA. Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 2004, 23(16): 2891-2906

[13] DickensLS, PowleyIR, HughesMA, et al.. The ‘complexities’ of life and death: death receptor signalling platforms. Exp Cell Res, 2012, 318(11): 1269-1277

[14] JustusSJ, TingAT. Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1. Immunol Rev, 2015, 266(1): 145-160

[15] BertrandMJ, MilutinovicS, DicksonKM, et al.. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Molecul Cell, 2008, 30(6): 689-700

[16] AlvarezSE, HarikumarKB, HaitNC, et al.. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature, 2010, 465(7301): 1084-1088

[17] HackerH, KarinM. Regulation and function of IKK and IKK-related kinases. Sci STKE, 2006, 2006(357): re13

[18] O’DonnellMA, Perez-JimenezE, OberstA, et al.. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol, 2011, 13(12): 1437-1442

[19] HeS, WangL, MiaoL, et al.. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell, 2009, 137(6): 1100-1111

[20] ChoYS, ChallaS, MoquinD, et al.. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell, 2009, 137(6): 1112-1123

[21] ZhangDW, ShaoJ, LinJ, et al.. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science, 2009, 325(5938): 332-336

[22] LiJ, McQuadeT, SiemerAB, et al.. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell, 2012, 150(2): 339-350

[23] ZhaoJ, JitkaewS, CaiZ, et al.. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA, 2012, 109(14): 5322-5327

[24] SunL, WangH, WangZ, et al.. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell, 2012, 148(1-2): 213-227

[25] ChenX, LiW, RenJ, et al.. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res, 2014, 24(1): 105-121

[26] ZhangD, LinJ, HanJ. Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol, 2010, 7(4): 243-249

[27] ZhangY, SuSS, ZhaoS, et al.. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun, 2017, 8: 14329

[28] TianF, YaoJ, YanM, et al.. 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells. Sci Rep, 2016, 6: 21992

[29] YangC, LiuX, YangF, et al.. Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury. In Vitro Cell Dev Biol Anim, 2017, 53(3): 248-257

[30] LueddeM, LutzM, CarterN, et al.. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res, 2014, 103(2): 206-216

[31] LusisAJ. Atherosclerosis. Nature, 2000, 407(6801): 233-241

[32] WangD, WangZ, ZhangL, et al.. Roles of Cells from the Arterial Vessel Wall in Atherosclerosis. Mediators Inflamm, 2017, 2017: 8135934

[33] LibbyP, RidkerPM, MaseriA. Inflammation and atherosclerosis. Circulation, 2002, 105(9): 1135-1143

[34] WangZ, GuoLM, WangSC, et al.. Progress in studies of necroptosis and its relationship to disease processes. Pathol Res Pract, 2018, 214(11): 1749-1757

[35] DargelR. The lipid infiltration theory of atherosclerosis. Z Med Lab Dign (German), 1989, 30(5): 251-255

[36] DhuriyaYK, SharmaD. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation, 2018, 15(1): 199

[37] KamannaVS, PaiR, HaH, et al.. Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int, 1999, 55(6): 2192-2202

[38] HeY, KwanWC, SteinbrecherUP. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis, 1996, 119(1): 107-118

[39] LinJ, LiH, YangM, et al.. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep, 2013, 3(1): 200-210

[40] SeimonTA, NadolskiMJ, LiaoX, et al.. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metabol, 2010, 12(5): 467-482

[41] KarunakaranD, GeoffrionM, WeiL, et al.. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv, 2016, 27: e1600224

[42] LeppanenO, BjornhedenT, EvaldssonM, et al.. ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis, 2006, 188(2): 323-330

[43] YamamuraT, YamamotoA, HiramoriK, et al.. A new isoform of apolipoprotein E—apo E-5—associated with hyperlipidemia and atherosclerosis. Atherosclerosis, 1984, 50(2): 159-172

[44] MahleyRW, InnerarityTL, RallSC, et al.. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia. Ann N Y Acad Sci, 1985, 454: 209-221

[45] TaniguchiT, YamasakiS. Apolipoproteins and atherosclerosis—study of apolipoprotein E. Rinsho Byori (Japanese), 1984, 32(7): 772-779

[46] MengL, JinW, WangY, et al.. RIP3-dependent necrosis induced inflammation exacerbates atherosclerosis. Biochem Biophys Res Commun, 2016, 473(2): 497-502

[47] ElluluMS, PatimahI, Khaza’aiH, et al.. Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology, 2016, 24(1): 1-10

[48] WangZ, GuoLM, ZhouHK, et al.. Using drugs to target necroptosis: dual roles in disease therapy. Histol Histopathol, 2018, 33(8): 773-789

[49] Ruiz-GinesJA, Lopez-OngilS, Gonzalez-RubioM, et al.. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol, 2000, 35(1): 109-113

[50] ShenAC, JenningsRB. Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol, 1972, 67(3): 441-452

[51] SjaastadI, BentzenJG, SembSO, et al.. Reduced calcium tolerance in rat cardiomyocytes after myocardial infarction. Acta Physiol Scand, 2002, 175(4): 261-269

[52] CardenDL, GrangerDN. Pathophysiology of ischaemia-reperfusion injury. J Pathol, 2000, 190(3): 255-266

[53] ZhangT, ZhangY, CuiM, et al.. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med, 2016, 22(2): 175-182

[54] LuW, SunJ, YoonJS, et al.. Mitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis. PloS One, 2016, 11(1): e0147792

[55] LiuX, ZhangC, ZhangC, et al.. Heat shock protein 70 inhibits cardiomyocyte necroptosis through repressing autophagy in myocardial ischemia/reperfusion injury. In Vitro Cell Dev Biol Anim, 2016, 52(6): 690-698

[56] DongXH, LiuH, ZhangMZ, et al.. Postconditioning with inhaled hydrogen attenuates skin ischemia/reperfusion injury through the RIP-MLKL-PGAM5/Drp1 necrotic pathway. Am J Transl Res, 2019, 11(1): 499-508

[57] GuoX, YinH, LiL, et al.. Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis. Circulation, 2017, 136(8): 729-742

[58] ZhangS, ZhouY, ZhaoL, et al.. kappa-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation. Eur J Pharmacol, 2018, 833: 100-108

[59] PengW, ZhangY, ZhuW, et al.. AMPK and TNF-alpha at the crossroad of cell survival and death in ischaemic heart. Cardiovasc Res, 2009, 84(1): 1-3

[60] HensleyN, DietrichJ, NyhanD, et al.. Hypertrophic cardiomyopathy: a review. Anesth Analg, 2015, 120(3): 554-569

[61] DrosatosK, SchulzePC. Savings precede spending: fatty acid utilization relies on triglyceride formation for cardiac energetics. Circulation, 2014, 130(20): 1775-1777

[62] ParkEJ, LeeAY, ParkS, et al.. Multiple pathways are involved in palmitic acid-induced toxicity. Food Chem Toxicol, 2014, 67: 26-34

[63] ZhaoM, LuL, LeiS, et al.. Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid. Oxid Med Cell Longev, 2016, 2016: 1451676

[64] KawanoH, OkadaR, KawanoY, et al.. Apoptosis in acute and chronic myocarditis. Jpn Heart J, 1994, 35(6): 745-750

[65] WhyHJ, MeanyBT, RichardsonPJ, et al.. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation, 1994, 89(6): 2582-2589

[66] WhelanRS, KaplinskiyV, KitsisRN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Ann Rev Physiol, 2010, 72: 19-44

[67] GaoX, ZhangH, ZhuangW, et al.. PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Sci Rep, 2014, 4: 5637

[68] SmithCC, DavidsonSM, LimSY, et al.. Necrostatin: a potentially novel cardioprotective agent?. Cardiovasc Drugs Ther, 2007, 21(4): 227-233

[69] LiuJ, WuP, WangY, et al.. Ad-HGF improves the cardiac remodeling of rat following myocardial infarction by upregulating autophagy and necroptosis and inhibiting apoptosis. Am J Transl Res, 2016, 8(11): 4605-4627